Industrially Relevant Enzyme Cascades for Drug Synthesis and Their Ecological Assessment
Open Access
- 25 March 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3605
Abstract
Environmentally friendly and sustainable processes for the production of active pharmaceutical ingredients (APIs) gain increasing attention. Biocatalytic synthesis routes with enzyme cascades support many stated green production principles, for example, the reduced need for solvents or the biodegradability of enzymes. Multi-enzyme reactions have even more advantages such as the shift of the equilibrium towards the product side, no intermediate isolation, and the synthesis of complex molecules in one reaction pot. Despite the intriguing benefits, only a few enzyme cascades have been applied in the pharmaceutical industry so far. However, several new enzyme cascades are currently being developed in research that could be of great importance to the pharmaceutical industry. Here, we present multi-enzymatic reactions for API synthesis that are close to an industrial application. Their performances are comparable or exceed their chemical counterparts. A few enzyme cascades that are still in development are also introduced in this review. Economic and ecological considerations are made for some example cascades to assess their environmental friendliness and applicability.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (445751305)
This publication has 75 references indexed in Scilit:
- Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosisBlood, 2013
- Statistical Experimental Design Guided Optimization of a One-Pot Biphasic Multienzyme Total Synthesis of Amorpha-4,11-dienePLOS ONE, 2013
- High-level semi-synthetic production of the potent antimalarial artemisininNature, 2013
- Environmental assessment of enzyme use in industrial production – a literature reviewJournal of Cleaner Production, 2013
- Enantioselective Total Synthesis of the Potent Anti-HIV Nucleoside EFdAOrganic Letters, 2011
- E factors, green chemistry and catalysis: an odysseyChemical Communications, 2008
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- Cradle-to-gate environmental assessment of enzyme products produced industrially in denmark by novozymes A/SThe International Journal of Life Cycle Assessment, 2006
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- 2′‐deoxy′4′‐C‐ethynyl‐2‐fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicityThe Chemical Record, 2006